FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma

FDA Commissioner Scott Gottlieb on Tuesday told a House Appropriations subcommittee that the agency plans to “sharply increase” its release of disease-focused guidance documents to help drugmakers develop new treatments.